Divisions of Infectious Diseases, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
J Infect Dis. 2010 Oct 15;202 Suppl 2(Suppl 2):S278-88. doi: 10.1086/655655.
Best practice for the clinical management of acute human immunodeficiency virus (HIV) infection remains unknown. Although some data suggest possible immunologic, virologic, or clinical benefit of early treatment, other studies show no difference in these outcomes over time, after early treatment is discontinued. The literature on acute HIV infection is predominantly small nonrandomized studies, which further limits interpretation. As a result, the physician is left to grapple with these uncertainties while making clinical decisions for patients with acute HIV infection. Here we review the literature, focusing on the potential advantages and disadvantages of treating acute HIV infection outlined in treatment guidelines, and summarize the presentations on clinical management of acute HIV infection from the 2009 Acute HIV Infection Meeting in Boston, Massachusetts.
急性人类免疫缺陷病毒 (HIV) 感染的临床管理最佳实践仍不清楚。虽然一些数据表明早期治疗可能具有免疫、病毒学或临床益处,但其他研究表明,早期治疗停止后,这些结果随时间没有差异。急性 HIV 感染的文献主要是小型非随机研究,这进一步限制了其解释。因此,医生在为急性 HIV 感染患者做出临床决策时,需要应对这些不确定性。在这里,我们回顾了文献,重点介绍了治疗指南中概述的治疗急性 HIV 感染的潜在优缺点,并总结了在马萨诸塞州波士顿举行的 2009 年急性 HIV 感染会议上关于急性 HIV 感染临床管理的介绍。